Silicon nanocrystals map location of spreading tumors

Jan 19, 2011

Nano-sized fluorescent particles known as quantum dots have shown promise as powerful imaging agents capable of detecting a wide range of diseases, but these nanoparticles are usually made with toxic metals such as cadmium. Now, researchers at the University of Buffalo have developed a novel synthetic method that enables them to design and create biocompatible fluorescent nanocrystals made of non-toxic silicon. More importantly, the investigators have used these silicon nanocrystals to image tumors and spot spreading cancer in lymph nodes.

Reporting its work in the journal ACS Nano, a team of investigators led by Paras Prasad describes the two-step process they use to prepare polymer-coated, fluorescent silicon nanoparticles to which they can attach a variety of tumor-targeting molecules, including a small peptide known as RGD that binds to the new blood vessels that surround tumors. This synthetic process allowed the researchers to prepare silicon nanocrystals of well-defined sizes, each with its own characteristic fluorescent emission peak. The polymer coating prevents the nanocrystals from being eliminated rapidly inside the body, a fate that normally awaits unprotected silicon particles in the body.

After demonstrating that RGD-derivatized nanocrystals were non-toxic in both cultured cell and whole animal studies, the investigators showed that they could use the nanocrystals to image pancreatic tumors growing in mice, and to detect tumors in tissue specimens removed for biopsy. The investigators also showed that they could use non-targeted silicon nanocrystals to map sentinel lymph nodes in mice, the lymph nodes where metastatic cells first accumulate when spreading through the body.

This work, which is detailed in a paper titled, "In vivo Targeted Cancer Imaging, Mapping and Multi-Channel Imaging with Biocompatible Silicon ," was supported in part by the NCI Alliance for Nanotechnology in Cancer, a comprehensive initiative designed to accelerate the application of nanotechnology to the prevention, diagnosis, and treatment of cancer. At the time of this work, Dr. Prasad was the principal investigator of one of 12 Cancer Nanotechnology Platform Partnerships funded during the NCI' Alliance's first five-year phase. An abstract of this paper is available at the journal's website.

Explore further: Molecular beacons shine light on how cells 'crawl'

More information: View the complete abstract here: http://dx.doi.org/doi:10.1021/nn1018945

add to favorites email to friend print save as pdf

Related Stories

Gold Nanobeacons Detect Sentinel Lymph Nodes

Mar 25, 2010

(PhysOrg.com) -- Virtually every patient diagnosed with breast cancer or melanoma undergoes lymph node biopsy to determine if their cancer has begun spreading in the body. Taking this biopsy involves an invasive and uncomfortable ...

Tracking tumor-targeting nanoparticles in the body

Oct 27, 2010

Though targeted nanoparticle-based imaging agents and therapeutics for diagnosing and treating cancer are making their way to and through the clinical trials process, researchers still do not have a good understanding of ...

Dual-Mode Nanoparticles Image Tumors Using MRI and PET

Aug 15, 2008

Medical imaging represents one of the most used and useful procedures in the oncologist’s diagnostic toolkit, even though each of the most useful techniques—magnetic resonance imaging (MRI), computerized tomography x-ray ...

Magnetic Nanocrystals Carry Tumor-Killing Drugs

Mar 07, 2007

Imagine using a focused magnetic field to concentrate anticancer drugs in and around tumors, and then turning off the magnetic field so that the drugs then leave the body. That possiblity may become a reality as a result ...

Nanoparticles Detect and Purge Metastases in Lymph Nodes

Oct 30, 2009

Colonoscopy represents one of the great weapons against cancer. In one step, a physician can find precancerous lesions in the colon and then cut them out, an on-the-spot intervention that prevents cancer from developing. ...

Nanoparticles Image Breast Cancer

Jul 21, 2009

Current methods of detecting breast cancer suffer from low sensitivity, limited spatial resolution, or the need to use complicated and expensive radioisotope-based technologies. A new report from investigators at the Emory-Georgia ...

Recommended for you

Molecular beacons shine light on how cells 'crawl'

Oct 24, 2014

Adherent cells, the kind that form the architecture of all multi-cellular organisms, are mechanically engineered with precise forces that allow them to move around and stick to things. Proteins called integrin ...

User comments : 0